In prostate cancer (PsC), the most frequently mutated genes were TP53 (93.33%), KDR (53.33%), MET (33.33%), HRAS (13.33%), APC (13.33%), and ATM (13.33%) (Supplementary Table 1). Here, MET is linked to prostate carcinoma.